Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Robinson

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Ophthalmic Plastic and Reconstructive Surgery|November 23, 2006
New corticosteroid-eluting porous polyethylene implant for the management of lower eyelid retraction: a pilot studyDaniel C Garibaldi, Michael R Robinson, Susan S Lee, et al.
American Journal of Ophthalmology|January 12, 2025
Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser TrabeculoplastyMiriam Kolko, Andrew J Tatham, Kin Sheng Lim, et al.
Drugs|February 22, 2025
Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)Steven M Silverstein, Francesco Oddone, Miriam Kolko, et al.
Investigative Ophthalmology & Visual Science|May 26, 2006
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitisBrian C Gilger, Jacklyn H Salmon, David A Wilkie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4Peter Attia, Giao Q Phan, Ajay V Maker, et al.
Science (New York, N.Y.)|September 21, 2002
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesMark E Dudley, John R Wunderlich, Paul F Robbins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanomaMark E Dudley, John R Wunderlich, James C Yang, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Ophthalmic Plastic and Reconstructive Surgery|November 23, 2006
New corticosteroid-eluting porous polyethylene implant for the management of lower eyelid retraction: a pilot studyDaniel C Garibaldi, Michael R Robinson, Susan S Lee, et al.
American Journal of Ophthalmology|January 12, 2025
Phase 3, Randomized, Comparison Study of Intracameral Bimatoprost Implant 10 µg and Selective Laser TrabeculoplastyMiriam Kolko, Andrew J Tatham, Kin Sheng Lim, et al.
Drugs|February 22, 2025
Safety and Longevity of Intraocular Pressure Control After Bimatoprost Implant Administration: Interim Analysis of a Phase 3b Clinical Trial (TRITON)Steven M Silverstein, Francesco Oddone, Miriam Kolko, et al.
Investigative Ophthalmology & Visual Science|May 26, 2006
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitisBrian C Gilger, Jacklyn H Salmon, David A Wilkie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2005
Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4Peter Attia, Giao Q Phan, Ajay V Maker, et al.
Science (New York, N.Y.)|September 21, 2002
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytesMark E Dudley, John R Wunderlich, Paul F Robbins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanomaMark E Dudley, John R Wunderlich, James C Yang, et al.
Pageof 8